Clinical Evaluation of a Daily Disposable Contact Lens in Symptomatic Weekly/Monthly Lens Wearers
This study has been completed.
Sponsor:
Alcon Research
Information provided by (Responsible Party):
Alcon Research
ClinicalTrials.gov Identifier:
NCT01614600
First received: June 6, 2012
Last updated: November 8, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the reduction of contact lens-related dryness symptoms when symptomatic weekly/monthly contact lens wearers are switched to DAILIES AquaComfort Plus lenses for a two-week period using composite scores on the Contact Lens Dry Eye (CLDE) Questionnaire.
| Condition | Intervention |
|---|---|
|
Dry Eye Myopia |
Device: nelfilcon A contact lens (DAILIES® AquaComfort Plus®) |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Clinical Evaluation of a Daily Disposable Contact Lens in Symptomatic Weekly/Monthly Lens Wearers |
Resource links provided by NLM:
Genetics Home Reference related topics:
keratitis-ichthyosis-deafness syndrome
MedlinePlus related topics:
Eye Wear
U.S. FDA Resources
Further study details as provided by Alcon Research:
Primary Outcome Measures:
- Mean change from baseline in contact lens-related dryness symptoms at 30 days [ Time Frame: Baseline, 30 days ] [ Designated as safety issue: No ]Contact lens symptoms will be measured using the Contact Lens Dry Eye Questionnaire (CLDEQ). Subjects will rate their frequency and severity of eight common contact lens-related symptoms to compile an average aggregate score.
| Enrollment: | 88 |
| Study Start Date: | June 2012 |
| Study Completion Date: | September 2012 |
| Primary Completion Date: | September 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: DACP
Contact lenses per participant's habitual prescription worn bilaterally on a daily wear, daily disposable basis for 30 days.
|
Device: nelfilcon A contact lens (DAILIES® AquaComfort Plus®)
Commercially marketed hydrogel contact lens for daily wear, daily disposable use
Other Name: DAILIES® AquaComfort Plus®
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Currently wearing weekly/monthly, silicone hydrogel or traditional hydrogel soft contact lenses at least 8 hours per day and 5 days a week during the past 6 months.
- Identified as symptomatic using a baseline screening questionnaire.
- Requires vision correction in both eyes with a contact lens Rx as follows: sphere powers between -0.50 and -10.00 D and cylinder powers </= 0.75D and no ADD correction.
- Able to achieve VA of at least 6/7.5 in each eye with study lenses in the available parameters.
- Willing to wear study lenses for at least 8 hours/day and at least 5 days/week and discard the lenses at the end of the day and replace lenses every day with a new fresh pair.
Willing and able to follow instructions and maintain the appointment schedule.
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Neophytes and current wearers of daily disposable contact lenses.
- Requires monovision correction.
- Any systemic or ocular disease or disorder (refractive disorder allowed) complicating factors or structural abnormality that would negatively affect the conduct or outcome of the study.
- A history of ocular surgery/trauma within the last 6 months.
- Unwilling to discontinue mechanical eyelid therapy or eyelid scrubs within 14 days of enrollment and continuing during the study.
Participation in any other ophthalmic drug or device clinical trial within 30 days of enrollment.
- Other protocol-defined exclusion criteria may apply.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01614600
Locations
| United States, Texas | |
| Contact Alcon Call Center for Trial Locations | |
| Fort Worth, Texas, United States, 76134 | |
Sponsors and Collaborators
Alcon Research
Investigators
| Study Director: | Director, Global Medical Affairs | Alcon Research |
More Information
No publications provided
| Responsible Party: | Alcon Research |
| ClinicalTrials.gov Identifier: | NCT01614600 History of Changes |
| Other Study ID Numbers: | A00849 |
| Study First Received: | June 6, 2012 |
| Last Updated: | November 8, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Alcon Research:
|
contact lens dry eye symptomatic daily disposable myopia |
Additional relevant MeSH terms:
|
Keratoconjunctivitis Sicca Dry Eye Syndromes Myopia Keratoconjunctivitis Conjunctivitis Conjunctival Diseases |
Eye Diseases Keratitis Corneal Diseases Lacrimal Apparatus Diseases Refractive Errors |
ClinicalTrials.gov processed this record on May 23, 2013